{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:50:44Z","timestamp":1780361444361,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Cerebral palsy (CP) is a heterogeneous group of disorders with different clinical types and underlying genetic variants. Children with CP are at risk for fragility fractures secondary to low bone mineral density, and although bisphosphonates are prescribed for the treatment of children with bone fragility, there is limited information on long-term bone impact and safety. Children with CP usually present overtubulated bones, and the thickening of cortical bone by pamidronate treatment can potentially further narrow the medullary canal. Our purpose was to report bone alterations attributable to pamidronate therapy that impact orthopedic care in children with CP. The study consisted of 41 children with CP treated with pamidronate for low bone mineral density from 2006 to 2020. Six children presented unique bone deformities and unusual radiologic features attributed to pamidronate treatment, which affected their orthopedic care. The cases included narrowing of the medullary canal and sclerotic bone, atypical femoral fracture, and heterotopic ossification. Treatment with bisphosphonate reduced the number of fractures from 101 in the pretreatment period to seven in the post-treatment period (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). In conclusion, children with CP treated with bisphosphonate have a reduction in low-energy fractures; however, some fractures still happen, and pamidronate treatment can lead to bone alterations including medullary canal narrowing with sclerotic bone and atypical femoral fractures. In very young children, failure to remodel may lead to thin, large femoral shafts with cystic medullary canals. More widespread use of bisphosphonates in children with CP may make these bone alterations more frequent. Level of evidence: Level IV: Case series with post-test outcomes.<\/jats:p>","DOI":"10.1097\/bpb.0000000000001136","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:11:08Z","timestamp":1696857068000},"page":"407-410","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management"],"prefix":"10.1097","volume":"33","author":[{"given":"Luiz Carlos","family":"Almeida Da Silva","sequence":"first","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Kaymaz","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Hori","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parma E.","family":"Montufar Wright","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Trionfo","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Howard","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Richard","family":"Bowen","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Wade","family":"Shrader","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freeman","family":"Miller","sequence":"additional","affiliation":[{"name":"Nemours Children\u2019s Health, Wilmington, Delaware, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajog.2015.05.034","article-title":"Cerebral palsy: causes, pathways, and the role of genetic variants.","volume":"213","author":"MacLennan","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/BPO.0000000000000421","article-title":"Pamidronate treatment to prevent reoccurring fractures in children with cerebral palsy.","volume":"36","author":"Sees","year":"2016","journal-title":"J Pediatr Orthop"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.pmrj.2013.10.009","article-title":"Bisphosphonate treatment for children with disabling conditions.","volume":"6","author":"Boyce","year":"2014","journal-title":"PM R"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1530\/EJE-08-0282","article-title":"Management of osteoporosis in children.","volume":"159","author":"Shaw","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1469-8749.2010.03676.x","article-title":"Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy.","volume":"52","author":"Bachrach","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/mpd.2002.128207","article-title":"Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial.","volume":"141","author":"Henderson","year":"2002","journal-title":"J Pediatr"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00198-008-0718-8","article-title":"Evaluation of the femoral midshaft in children with cerebral palsy using magnetic resonance imaging.","volume":"20","author":"Modlesky","year":"2009","journal-title":"Osteoporos Int"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00256-020-03465-1","article-title":"Glossary of terms for musculoskeletal radiology.","volume":"49","author":"Palmer","year":"2020","journal-title":"Skeletal Radiol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"770931","DOI":"10.3389\/fcell.2022.770931","article-title":"Heterotopic ossification: clinical features, basic researches, and mechanical stimulations.","volume":"10","author":"Xu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2010-2546","article-title":"Approach to the child with fractures.","volume":"96","author":"Boyce","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.bpo.0000217725.16417.af","article-title":"Heterotopic ossification following hip osteotomies in cerebral palsy: incidence and risk factors.","volume":"26","author":"Inan","year":"2006","journal-title":"J Pediatr Orthop"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: bisphosphonate use in childhood osteoporosis.","volume":"94","author":"Bachrach","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/BPO.0000000000000552","article-title":"Unusual femur stress fractures in children with osteogenesis imperfecta and intramedullary rods on long-term intravenous pamidronate therapy.","volume":"36","author":"Hegazy","year":"2016","journal-title":"J Pediatr Orthop"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocd.2009.01.005","article-title":"Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery\/Delphi dual-energy X-ray absorptiometry.","volume":"12","author":"Zemel","year":"2009","journal-title":"J Clin Densitom"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2214\/ajr.178.2.1780439","article-title":"Pediatric reference data for dual X-ray absorptiometric measures of normal bone density in the distal femur.","volume":"178","author":"Henderson","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.091007","article-title":"The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy.","volume":"25","author":"Henderson","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/230949901202000125","article-title":"Femoral canal obliteration secondary to prolonged alendronate use: a case report.","volume":"20","author":"Lim","year":"2012","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1359\/JBMR.051207","article-title":"Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.","volume":"21","author":"Land","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1302\/0301-620X.86B7.15273","article-title":"A flexible intramedullary nails for fractures in children.","volume":"86","author":"Barry","year":"2004","journal-title":"J Bone Joint Surg Br"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BPB.0000000000000598","article-title":"Personalized surgery approach in severe form of osteogenesis imperfecta type III: point of view.","volume":"28","author":"Jele\u010d","year":"2019","journal-title":"J Pediatr Orthop B"}],"container-title":["Journal of Pediatric Orthopaedics B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BPB.0000000000001136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:49Z","timestamp":1748296849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BPB.0000000000001136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bpb.0000000000001136","relation":{},"ISSN":["1060-152X"],"issn-type":[{"value":"1060-152X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}